(Q47826083)

5 February 2018

title

A treatment algorithm for autoimmune myasthenia gravis in childhood. (English)

1 reference

5 February 2018

0 references

Andrews PI

1

1 reference

5 February 2018

language of work or name

English

0 references

publication date

1 May 1998

1 reference

5 February 2018

Annals of the New York Academy of Sciences

published in

1 reference

5 February 2018

volume

841

1 reference

5 February 2018

page(s)

789-802

1 reference

5 February 2018

Myasthenia gravis: immunological mechanisms and immunotherapy

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB11020.X

Acetylcholine receptor antibodies in juvenile myasthenia gravis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB11020.X

Early-onset myasthenia gravis: clinical characteristics and response to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB11020.X

Race, sex, and puberty influence onset, severity, and outcome in juvenile myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB11020.X

The epidemiology of myasthenia gravis in central and western Virginia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB11020.X

Functional histology of the human thymus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB11020.X

Myasthenic crisis. Response to plasmapheresis following failure of intravenous gamma-globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB11020.X

Complications of intravenous immune globulin treatment in neurologic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB11020.X

Follow-up study of myasthenic children after thymectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB11020.X

Extended thymectomy for myasthenia gravis patients: a 20-year review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB11020.X

Delayed remission after thymectomy for myasthenia gravis of the purely ocular type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB11020.X

Thymectomy and Cancer—A Follow-Up Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB11020.X

Beneficial effects of corticosteroids on ocular myasthenia gravis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB11020.X

High-dose intravenous methylprednisolone in myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB11020.X

Sudden death after methylprednisolone pulse therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB11020.X

Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB11020.X

10.1111/J.1749-6632.1998.TB11020.X

21 January 2018

Identifiers

DOI

1 reference

5 February 2018

1 reference

5 February 2018